Tarbox Family Office’s Biolase, Inc. BIOL Stock Holding History

Tarbox Family Office’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	-$3K	–	1042
2022 Q1	$3K	Hold	3	–	–	﹤0.01%	750
2021 Q4	$3K	Hold	3	–	–	﹤0.01%	824
2021 Q3	$5K	Hold	3	–	–	﹤0.01%	670
2021 Q2	$5K	Hold	3	–	–	﹤0.01%	670
2021 Q1	$7K	Hold	3	–	–	﹤0.01%	491
2020 Q4	$3K	Hold	3	–	–	﹤0.01%	756
2020 Q3	$2K	Hold	3	–	–	﹤0.01%	868
2020 Q2	$4K	Hold	3	–	–	﹤0.01%	573
2020 Q1	$3K	Hold	3	–	–	﹤0.01%	578
2019 Q4	$4K	Hold	3	–	–	﹤0.01%	612
2019 Q3	$7K	Hold	3	–	–	﹤0.01%	407
2019 Q2	$11K	Hold	3	–	–	﹤0.01%	328
2019 Q1	$19K	Hold	3	–	–	0.01%	236
2018 Q4	$8K	Sell	3 -3	-50%	-$9.69K	﹤0.01%	328
2018 Q3	$33K	Buy	6 +3	+100%	+$12K	0.01%	189
2018 Q2	$9K	Sell	3 -3	-50%	-$11.3K	﹤0.01%	322
2018 Q1	$32K	Buy	+6	New	+$33.7K	0.01%	191

Other funds holding BIOL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tarbox Family Office's BIOL Position: Q2 2022 in Review

Tarbox Family Office sold out of Biolase, Inc. (BIOL) in Q2 2022, closing a stake of 3 shares — an estimated $3K sold.

Tarbox Family Office first reported a position in BIOL in Q1 2018 and held it in 17 quarters. The position peaked at $33K in Q3 2018. 16 funds tracked by Wall St. Rank hold BIOL as of Q2 2022.

Tarbox Family Office reported no remaining Biolase, Inc. position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 3 Biolase, Inc. shares in Q2 2022, an estimated $3K.
Tarbox Family Office first reported a position in Biolase, Inc. in Q1 2018 and held it in 17 quarters.
Tarbox Family Office's Biolase, Inc. position peaked at $33K in Q3 2018.
16 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.